161 related articles for article (PubMed ID: 21420984)
41. Long-lasting inhibition of in vivo cocaine binding to dopamine transporters by 3 beta-(4-iodophenyl)tropane-2-carboxylic acid methyl ester: RTI-55 or beta CIT.
Volkow ND; Gatley SJ; Fowler JS; Chen R; Logan J; Dewey SL; Ding YS; Pappas N; King P; MacGregor RR
Synapse; 1995 Mar; 19(3):206-11. PubMed ID: 7784960
[TBL] [Abstract][Full Text] [Related]
42. Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type.
Eshleman AJ; Carmolli M; Cumbay M; Martens CR; Neve KA; Janowsky A
J Pharmacol Exp Ther; 1999 May; 289(2):877-85. PubMed ID: 10215666
[TBL] [Abstract][Full Text] [Related]
43. Dopamine transporter synthesis and degradation rate in rat striatum and nucleus accumbens using RTI-76.
Kimmel HL; Carroll FI; Kuhar MJ
Neuropharmacology; 2000 Feb; 39(4):578-85. PubMed ID: 10728879
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and monoamine transporter binding properties of 3alpha-(substituted phenyl)nortropane-2beta-carboxylic acid methyl esters. Norepinephrine transporter selective compounds.
Carroll FI; Tyagi S; Blough BE; Kuhar MJ; Navarro HA
J Med Chem; 2005 Jun; 48(11):3852-7. PubMed ID: 15916437
[TBL] [Abstract][Full Text] [Related]
45. Studies of the biogenic amine transporters. VII. Characterization of a novel cocaine binding site identified with [125I]RTI-55 in membranes prepared from human, monkey and guinea pig caudate.
Rothman RB; Silverthorn ML; Glowa JR; Matecka D; Rice KC; Carroll FI; Partilla JS; Uhl GR; Vandenbergh DJ; Dersch CM
Synapse; 1998 Apr; 28(4):322-38. PubMed ID: 9517841
[TBL] [Abstract][Full Text] [Related]
46. Molecular dynamics of conformation-specific dopamine transporter-inhibitor complexes.
Jean B; Surratt CK; Madura JD
J Mol Graph Model; 2017 Sep; 76():143-151. PubMed ID: 28734204
[TBL] [Abstract][Full Text] [Related]
47. Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.
Lee SH; Chang MY; Lee KH; Park BS; Lee YS; Chin HR; Lee YS
Mol Pharmacol; 2000 May; 57(5):883-9. PubMed ID: 10779370
[TBL] [Abstract][Full Text] [Related]
48. Biophysical characterization of the cocaine binding pocket in the serotonin transporter using a fluorescent cocaine analogue as a molecular reporter.
Rasmussen SG; Carroll FI; Maresch MJ; Jensen AD; Tate CG; Gether U
J Biol Chem; 2001 Feb; 276(7):4717-23. PubMed ID: 11062247
[TBL] [Abstract][Full Text] [Related]
49. Structure-activity relationship studies on a novel series of (S)-2beta-substituted 3alpha-[bis(4-fluoro- or 4-chlorophenyl)methoxy]tropane analogues for in vivo investigation.
Zou MF; Cao J; Kopajtic T; Desai RI; Katz JL; Newman AH
J Med Chem; 2006 Oct; 49(21):6391-9. PubMed ID: 17034144
[TBL] [Abstract][Full Text] [Related]
50. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
51. In vivo binding of [125I]RTI-55 to dopamine transporters: pharmacology and regional distribution with autoradiography.
Cline EJ; Scheffel U; Boja JW; Mitchell WM; Carroll FI; Abraham P; Lewin AH; Kuhar MJ
Synapse; 1992 Sep; 12(1):37-46. PubMed ID: 1411962
[TBL] [Abstract][Full Text] [Related]
52. Displacement of RTI-55 from the dopamine transporter by cocaine.
Gatley SJ; Volkow ND; Chen R; Fowler JS; Carroll FI; Kuhar MJ
Eur J Pharmacol; 1996 Jan; 296(2):145-51. PubMed ID: 8838450
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation of dopamine transporter serine 7 modulates cocaine analog binding.
Moritz AE; Foster JD; Gorentla BK; Mazei-Robison MS; Yang JW; Sitte HH; Blakely RD; Vaughan RA
J Biol Chem; 2013 Jan; 288(1):20-32. PubMed ID: 23161550
[TBL] [Abstract][Full Text] [Related]
54. Cloning of dopamine, norepinephrine and serotonin transporters from monkey brain: relevance to cocaine sensitivity.
Miller GM; Yatin SM; De La Garza R; Goulet M; Madras BK
Brain Res Mol Brain Res; 2001 Feb; 87(1):124-43. PubMed ID: 11223167
[TBL] [Abstract][Full Text] [Related]
55. Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB.
Sahai MA; Davidson C; Khelashvili G; Barrese V; Dutta N; Weinstein H; Opacka-Juffry J
Prog Neuropsychopharmacol Biol Psychiatry; 2017 Apr; 75():1-9. PubMed ID: 27890676
[TBL] [Abstract][Full Text] [Related]
56. Dopamine transporter binding without cocaine-like behavioral effects: synthesis and evaluation of benztropine analogs alone and in combination with cocaine in rodents.
Katz JL; Agoston GE; Alling KL; Kline RH; Forster MJ; Woolverton WL; Kopajtic TA; Newman AH
Psychopharmacology (Berl); 2001 Apr; 154(4):362-74. PubMed ID: 11349389
[TBL] [Abstract][Full Text] [Related]
57. Human placenta as a target organ for cocaine action: interaction of cocaine with the placental serotonin transporter.
Prasad PD; Leibach FH; Mahesh VB; Ganapathy V
Placenta; 1994 Apr; 15(3):267-78. PubMed ID: 8066050
[TBL] [Abstract][Full Text] [Related]
58. Cocaine-like discriminative stimulus effects of novel cocaine and 3-phenyltropane analogs in the rat.
Cook CD; Carroll IF; Beardsley PM
Psychopharmacology (Berl); 2001 Dec; 159(1):58-63. PubMed ID: 11797070
[TBL] [Abstract][Full Text] [Related]
59. Dissociation of high-affinity cocaine analog binding and dopamine uptake inhibition at the dopamine transporter.
Wang W; Sonders MS; Ukairo OT; Scott H; Kloetzel MK; Surratt CK
Mol Pharmacol; 2003 Aug; 64(2):430-9. PubMed ID: 12869648
[TBL] [Abstract][Full Text] [Related]
60. Dopamine transporter (DAT) inhibitors alleviate specific parkinsonian deficits in monkeys: association with DAT occupancy in vivo.
Madras BK; Fahey MA; Goulet M; Lin Z; Bendor J; Goodrich C; Meltzer PC; Elmaleh DR; Livni E; Bonab AA; Fischman AJ
J Pharmacol Exp Ther; 2006 Nov; 319(2):570-85. PubMed ID: 16885433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
